Tricida, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for patients with chronic kidney disease. The company specializes in the research and development of novel treatments aimed at addressing unmet medical needs in this domain. Tricida's primary technology platform is centered around its proprietary drug candidates, which are designed to improve patient outcomes and enhance quality of life for those affected by kidney-related conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#98 in South San Francisco, CA

#6,544 in California

#27,529 in US

#51,801 in the World

South San Francisco, CA, United States of America

Tricida, Inc.

Forward Citations = 92

12 inventors:

Gerrit Klaerner (11 out of 50 patents)

Eric F Connor (10 out of 45 patents)

Randi K Gbur (10 out of 13 patents)

4. Matthew J Kade (10 out of 13 patents)

5. Paul H Kierstead (10 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tricida, Inc.. Retrieved from https://idiyas.com/company/tricida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]